Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more
Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.245 | 17.1929824561 | 1.425 | 3.3 | 1.38 | 14249695 | 2.32458983 | CS |
| 4 | -0.7791 | -31.8116859254 | 2.4491 | 3.3 | 1.38 | 3825772 | 2.31874942 | CS |
| 12 | -1.97 | -54.1208791209 | 3.64 | 4.318 | 1.38 | 1307976 | 2.35648647 | CS |
| 26 | -2.9 | -63.4573304158 | 4.57 | 5.15 | 1.38 | 639831 | 2.43957019 | CS |
| 52 | -6.88 | -80.4678362573 | 8.55 | 22.35 | 1.38 | 1250718 | 8.96391039 | CS |
| 156 | -1385.83 | -99.8796396396 | 1387.5 | 1402.425 | 1.38 | 2000387 | 126.75781734 | CS |
| 260 | -6748.33 | -99.9752592593 | 6750 | 8182.5 | 1.38 | 1770951 | 328.79823075 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
